Our product is a food additive of biological origin with antiparasitic activity that mitigates caligidosis in salmonids. It does not cause stress, is harmless to the environment, and
is effective against adults and larvae of Caligus rogercresseyi and Lepeophtheirus salmonis. It can be administered preventively without harming the fish or the environment. The biological origin of our antiparasitic allows it to be administered over long periods of time and at all stages of salmon life in seawater until harvest, as the product does not require a withdrawal period. This is a major difference from Gold Standard products, which cannot be applied in the periods close to harvest because, being chemical, they require the elimination of traces of the product in the fillet (withdrawal period). This implies a high risk of mortality for fish, in which investment has been made throughout their growth stage, with the economic losses that this entails.

Our product is biological in origin, safe and harmless to fish, humans, and animals, does not harm the environment, and is effective against adult parasites and larvae. It is administered orally, meaning no stress for the fish, mixes easily with feed, and fits in with current production strategies. Furthermore, its mechanism of action is multifactorial, which makes it difficult for resistance to develop. In addition, it can be applied throughout the entire production cycle of salmon in seawater, making it a fundamental tool for treatment in the final stage of the salmon life cycle (until harvest), which allows for a longer growth period, resulting in considerable profits.
In in vitro trials, we have demonstrated that our antiparasitic agent applied directly (in Petri dishes) to adult and larval sea lice produces between 85 and 100% mortality.
In in vivo trials, the antiparasitic administered orally to fish showed dose-dependent protection results. We are currently optimizing the feed additive to increase its concentration and bioavailability in order to achieve greater effectiveness.

The target market is salmon producers affected by sea lice, located in Chile and Norway, whose size is estimated at more than $840 million annually. Chile is the second largest producer of salmonids in the world, contributing one-third of global production of this product (Sernapesca, 2023). The FAO expects aquaculture to grow by 32% from 2018 to 2030 in response to increased demand for protein for a growing world population.